Skip to main content
Top

05-24-2018 | Diet | Article

Intake of cocoa products and risk of type-2 diabetes: the multiethnic cohort

Journal: European Journal of Clinical Nutrition

Authors: Gertraud Maskarinec, Simone Jacobs, Yurii Shvetsov, Carol J. Boushey, Veronica W. Setiawan, Laurence N. Kolonel, Christopher A. Haiman, Loïc Le Marchand

Publisher: Nature Publishing Group UK

Abstract

Background/objectives

As cocoa products may be protective against chronic disease due to their polyphenol content, the current study determined the association of chocolate consumption and flavanol intake with type-2 diabetes (T2D) incidence in the Multiethnic Cohort (MEC) Study.

Subjects/methods

The analysis included 151,691 participants of Native Hawaiian, Japanese American, Latino, African American, and white ancestry with 8487 incident T2D cases after 7.8 ± 3.5 years of follow-up. T2D status was based on three self-reports and confirmed by at least one of three administrative data sources. Dietary intake was assessed using a validated quantitative food frequency questionnaire, and flavanols from cocoa products were estimated from self-reported consumption of chocolate candy and drinks. Cox hazard regression, adjusted for potential confounders was applied to estimate hazard ratios (HR) and 95% confidence intervals (CI).

Results

For chocolate candy, both the highest vs. lowest (≥10 vs. <1 g/day) consumption (HR = 0.90; 95% CI, 0.83–0.97; ptrend = 0.01) and the frequency (≥4/week vs. <1/month) of intake (HR = 0.81; 95% CI, 0.72–0.91; ptrend = 0.0002) were inversely associated with T2D. The estimated flavanol intake from cocoa products (≥3 vs. <1 mg/day) also showed an inverse association with T2D risk (HR = 0.93; 95% CI, 0.88–0.99; ptrend = 0.02). Significant interaction terms indicated that the inverse relation was limited to Japanese Americans, normal-weight individuals, and to those without comorbidities.

Conclusions

The current study confirms previous reports that participants with high intake of chocolate products and cocoa-derived flavanols experience a reduced risk of developing T2D even after controlling for sugar intake, diet quality, and other aspects of the diet.
Literature
1.
Gu L, House SE, Wu X, Ou B, Prior RL. Procyanidin and catechin contents and antioxidant capacity of cocoa and chocolate products. J Agric Food Chem. 2006;54:4057–61.CrossRef
2.
Strat KM, Rowley TJ, Smithson AT, Tessem JS, Hulver MW, Liu D. et al. Mechanisms by which cocoa flavanols improve metabolic syndrome and related disorders. J Nutr Biochem. 2016;35:1–21.CrossRef
3.
Grassi D, Desideri G, Ferri C. Protective effects of dark chocolate on endothelial function and diabetes. Curr Opin Clin Nutr Metab Care. 2013;16:662–8.CrossRef
4.
Ried K, Sullivan TR, Fakler P, Frank OR, Stocks NP. Effect of cocoa on blood pressure. Cochrane Database Syst Rev. 2012;8:CD008893
5.
di Giuseppe R, Di Castelnuovo A, Centritto F, Zito F, De Curtis A, Costanzo S. et al. Regular consumption of dark chocolate is associated with low serum concentrations of C-reactive protein in a healthy Italian population. J Nutr. 2008;138:1939–45.CrossRef
6.
Grassi D, Desideri G, Mai F, Martella L, De FM, Soddu D. et al. Cocoa, glucose tolerance and insulin signalling: the cardiometabolic protection. J Agric Food Chem. 2015;63:9919–26.CrossRef
7.
Perez-Jimenez J, Neveu V, Vos F, Scalbert A. Identification of the 100 richest dietary sources of polyphenols: an application of the Phenol-Explorer database. Eur J Clin Nutr. 2010;64(Suppl 3):S112–S120.CrossRef
8.
Buitrago-Lopez A, Sanderson J, Johnson L, Warnakula S, Wood A, Di AE, et al. Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ. 2011;343:d4488.CrossRef
9.
Oba S, Nagata C, Nakamura K, Fujii K, Kawachi T, Takatsuka N, et al. Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content in relation to risk of diabetes in Japanese men and women. Br J Nutr. 2010;103:453–9.CrossRef
10.
Greenberg JA. Chocolate intake and diabetes risk. Clin Nutr. 2015;34:129–33.CrossRef
11.
Matsumoto C, Petrone AB, Sesso HD, Gaziano JM, Djousse L. Chocolate consumption and risk of diabetes mellitus in the Physicians’ Health Study. Am J Clin Nutr. 2015;101:362–7.CrossRef
12.
Crichton GE, Elias MF, Dearborn P, Robbins M. Habitual chocolate intake and type 2 diabetes mellitus in the Maine-Syracuse Longitudinal Study: (1975-2010): Prospective observations. Appetite. 2017;108:263–9.CrossRef
13.
Zamora-Ros R, Forouhi NG, Sharp SJ, Gonzalez CA, Buijsse B, Guevara M, et al. Dietary intakes of individual flavanols and flavonols are inversely associated with incident type 2 diabetes in European populations. J Nutr. 2014;144:335–43.CrossRef
14.
International Diabetes Federation. IDF diabetes atlas. Bruxelles, Belgium:IDF; 2015.
15.
Maskarinec G, Grandinetti A, Matsuura G, Sharma S, Mau M, Henderson BE, et al. Diabetes prevalence and body mass index differ by ethnicity: the Multiethnic Cohort. Ethn Dis. 2009;19:49–55.PubMedPubMedCentral
16.
Kolonel LN, Henderson BE, Hankin JH, Nomura AMY, Wilkens LR, Pike MC, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol. 2000;151:346–57.CrossRef
17.
Murphy SP. Unique nutrition support for research at the Cancer Research Center of Hawaii. Hawaii Med J. 2002;61:1. 17
18.
Stram DO, Hankin JH, Wilkens LR, Henderson B, Kolonel LN. Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol. 2000;151:358–70.CrossRef
19.
Neveu V, Perez-Jimenez J, Vos F, Crespy V, du CL, Mennen L, et al. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database. 2010;2010:bap024.CrossRef
20.
Statistica. Milk and dark chocolate consumption in the United States in 2010. www.​statista.​com/​statistics/​238730/​milk-and-dark-chocolate-consumption-in-the-us-by-age-group/​ (2017). Accessed 7 February 2017.
21.
Jacobs S, Harmon BE, Boushey CJ, Morimoto Y, Wilkens LR, Le ML, et al. A priori-defined diet quality indexes and risk of type 2 diabetes: the Multiethnic Cohort. Diabetologia. 2015;58:98–112.CrossRef
22.
Harmon BE, Boushey CJ, Shvetsov YB, Ettienne R, Reedy J, Wilkens LR, et al. Associations of key diet-quality indexes with mortality in the Multiethnic Cohort: the dietary patterns methods project. Am J Clin Nutr. 2015;101:587–97.CrossRef
23.
Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med. 2008;168:713–20.CrossRef
24.
Maskarinec G, Erber E, Grandinetti A, Verheus M, Oum R, Hopping BN, et al. Diabetes incidence based on linkages with health plans: the multiethnic cohort. Diabetes. 2009;58:1732–8.CrossRef
25.
State of California Office of Statewide Health Planning & Development. Health care information division—patient discharge data. http://​www.​oshpd.​ca.​gov/​HID/​Products/​PatDischargeData​/​PublicDataSet/​index.​html (2015). Accessed 7 September 2015.
26.
Setiawan VW, Virnig BA, Porcel J, Henderson BE, Le ML, Wilkens LR, et al. Linking data from the Multiethnic Cohort Study to Medicare data: linkage results and application to chronic disease research. Am J Epidemiol. 2015;181:917–9.CrossRef
27.
Jacobs S, Boushey CJ, Franke AA, Shvetsov YB, Monroe KR, Haiman CA, et al. A priori-defined diet quality indices, biomarkers and risk for type 2 diabetes in five ethnic groups: the Multiethnic Cohort. Br J Nutr. 2017;118:312–20.CrossRef
28.
Maskarinec G, Jacobs S, Amshoff Y, Setiawan VW, Shvetsov YB, Franke AA, et al. Sleep duration and incidence of type 2 diabetes: the Multiethnic Cohort. Sleep Health. 2018;4:27–32.CrossRef
29.
Chronic Condition Data Warehouse. Condition categories. https://​www.​ccwdata.​org/​web/​guest/​condition-categories (2014). Accessed 7 March 2015.
30.
Steinbrecher A, Morimoto Y, Heak S, Ollberding NJ, Geller KS, Grandinetti A, et al. The preventable proportion of type 2 diabetes by ethnicity: the multiethnic cohort. Ann Epidemiol. 2011;21:526–35.CrossRef
31.
Doo T, Morimoto Y, Steinbrecher A, Kolonel LN, Maskarinec G. Coffee intake and risk of type 2 diabetes: the Multiethnic Cohort. Public Health Nutr. 2013; 17:1328–36.
32.
O’Neil CE, Fulgoni VL III, Nicklas TA. Candy consumption was not associated with body weight measures, risk factors for cardiovascular disease, or metabolic syndrome in US adults: NHANES 1999-2004. Nutr Res. 2011;31:122–30.CrossRef
33.
Greenberg JA, Manson JE, Buijsse B, Wang L, Allison MA, Neuhouser ML, et al. Chocolate-candy consumption and 3-year weight gain among postmenopausal U.S. women. Obesity. 2015;23:677–83.CrossRef
34.
Taubert D, Roesen R, Lehmann C, Jung N, Schomig E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA. 2007;298:49–60.CrossRef
35.
Grassi D, Desideri G, Necozione S, Lippi C, Casale R, Properzi G, et al. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr. 2008;138:1671–6.CrossRef
36.
Hooper L, Kay C, Abdelhamid A, Kroon PA, Cohn JS, Rimm EB, et al. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr. 2012;95:740–51.CrossRef
37.
Lin X, Zhang I, Li A, Manson JE, Sesso HD, Wang L, et al. Cocoa flavanol intake and biomarkers for cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials. J Nutr. 2016;146:2325–33.CrossRef
38.
Tzounis X, Rodriguez-Mateos A, Vulevic J, Gibson GR, Kwik-Uribe C, Spencer JP. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr. 2011;93:62–72.CrossRef
39.
Etxeberria U, Fernandez-Quintela A, Milagro FI, Aguirre L, Martinez JA, Portillo MP. Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J Agric Food Chem. 2013;61:9517–33.CrossRef
40.
Jang S, Sun J, Chen P, Lakshman S, Molokin A, Harnly JM, et al. Flavanol-enriched cocoa powder alters the intestinal microbiota, tissue and fluid metabolite profiles, and intestinal gene expression in pigs. J Nutr. 2016;146:673–80.CrossRef

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »